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Iron is essential for growth of Mycobacterium tuberculosis, the causative agent of tuberculosis.
To acquire iron from the host, M. tuberculosis uses the siderophores called mycobactins and
carboxymycobactins. Here, we show that the rv0455c gene is essential for M. tuberculosis to
grow in low-iron medium and that secretion of both mycobactins and carboxymycobactins is
drastically reduced in the rv0455c deletion mutant. Both water-soluble and membraneanchored Rv0455c are functional in siderophore secretion, supporting an intracellular role.
Lack of Rv0455c results in siderophore toxicity, a phenotype observed for other siderophore
secretion mutants, and severely impairs replication of M. tuberculosis in mice, demonstrating
the importance of Rv0455c and siderophore secretion during disease. The crystal structure of
a Rv0455c homolog reveals a novel protein fold consisting of a helical bundle with a ‘cinch’
formed by an essential intramolecular disulﬁde bond. These ﬁndings advance our understanding of the distinct M. tuberculosis siderophore secretion system.
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ron is an essential element for almost all living organisms as it
is utilized in a wide range of metabolic processes, including
oxygen transport, DNA synthesis, and electron transport1.
However, free iron is not easily accessible for microbes in the
presence of oxygen and at neutral pH2. In vertebrates, almost all
iron is tightly bound to host proteins such as ferritin, transferrin,
lactoferrin, hemoglobin, cytochromes, or iron-sulfur cluster
proteins3, reducing the iron availability and limiting the replication of pathogenic bacteria, especially of chronic pathogens with
long in vivo life cycles4. To overcome iron limitation, Mycobacterium tuberculosis, the causative agent of tuberculosis,
acquires iron from heme5 and solubilizes Fe(III) using
hydroxyphenyl-oxazolone siderophores, namely the hydrophobic
mycobactins and the water-soluble carboxymycobactins, which
share the same high-afﬁnity iron-binding core6. While mycobactins are mainly membrane-associated and carboxymycobactins are secreted, both siderophores are detected in the
culture ﬁltrate of M. tuberculosis7,8 demonstrating that not only
carboxymycobactins but also mycobactins are secreted. This is
consistent with the observation that lipid vesicles secreted by M.
tuberculosis contain mycobactin9. Importantly, addition of
mycobactin or carboxymycobactin to the culture medium rescues
the growth of an M. tuberculosis mycobactin synthesis mutant in
low-iron medium demonstrating that both classes of siderophores
are functionally identical in iron acquisition10. These siderophores are essential for growth of M. tuberculosis in
macrophages11. During their synthesis, MBTs and carboxymycobactins are maintained in an iron-free state in their deoxy
forms until the iron-binding sites are activated by enzymemediated oxidation12. The active siderophores are then exported
across the inner membrane by the efﬂux pumps MmpL4 and
MmpL5 and their associated MmpS4 and MmpS5 proteins7,10.
Lack of both mmpS4 and mmpS5 genes abolishes siderophore
secretion and results in strong attenuation of virulence of M.
tuberculosis in mice7.
However, it is unclear how mycobactins and carboxymycobactins are transported through the periplasm and across
the outer membrane to function as siderophores. Proteins mediating these steps required for siderophore secretion are unknown
and cannot be identiﬁed by sequence, since M. tuberculosis does
not have homologs to TolC, which provides a periplasmic tunnel
by docking to various efﬂux pumps via periplasmic adapter
proteins and an outer membrane channel for secretion of the
siderophore enterobactin by E. coli13,14.
In this study, we show that the mycobacterial core protein
Rv0455c, a 14-kDa exported protein of previously unknown
function, is required for siderophore secretion by M. tuberculosis.
Similar quantities of Rv0455c protein are localized in the periplasm of M. tuberculosis and are secreted into the culture medium, but Rv0455c exerts its function in siderophore secretion in
the periplasm. The crystal structure of the Rv0455c homolog
MSMEG_3494 from M. smegmatis reveals a novel structure
consisting of a helical bundle with a cinch topology established by
a disulﬁde bond formed by two essential cysteines. M. tuberculosis
lacking rv0455c is attenuated in mice providing evidence that
single proteins required for siderophore secretion exist and validating siderophore secretion as a target for tuberculosis drugs
with a new mechanism of action. This study represents a major
step forward in understanding the novel M. tuberculosis siderophore secretion system.
Results
Deletion of rv0455c gene renders M. tuberculosis hypersensitive
to exogenous mycobactin or carboxymycobactin. In a previous
Tn-seq study, we found that M. tuberculosis does not tolerate
2

transposon insertions in the rv0455c gene in medium containing
mycobactin even in the presence of hemin, while rv0455c is dispensable for growth of M. tuberculosis with hemin or hemoglobin
as sole iron sources10. This phenotype is similar to that observed
for the siderophore secretion-deﬁcient mmpS4/mmpS5 deletion
mutant of M. tuberculosis15 and was termed siderophore
poisoning10. To investigate whether Rv0455c is involved in
siderophore secretion by M. tuberculosis, the rv0455c gene was
deleted in both the avirulent M. tuberculosis strain mc26230
(H37Rv ΔRD1 ΔpanCD) and the virulent M. tuberculosis H37Rv
strain by homologous recombination (Fig. S1a–c). The M.
tuberculosis Δrv0455c mutant ML2203 (Table S1) derived from
M. tuberculosis mc26230 hardly grew in low-iron 7H9 medium
(<0.1 μM Fe3+). In contrast, both the parent strain or M. tuberculosis ML2203 complemented with an integrative vector
expressing rv0455c showed logarithmic growth and stationary
phase survival (Fig. 1a). The growth defect was similar to that
observed for the M. tuberculosis strains lacking the mmpS4/
mmpS5 genes (M. tuberculosis ML859) or the mycobactin
synthesis gene mbtD (M. tuberculosis ML1600) (Table S1). Further, the Δrv0455c mutant, as well as the siderophore secretiondeﬁcient mutant ΔmmpS4/ΔmmpS5, exhibited signiﬁcantly
reduced growth in the self-made 7H9 medium with Fe3+ concentrations ranging from 1 μM to 100 μM, compared to M.
tuberculosis mc26230 (Fig. S1d), indicating that the ability of both
mutants to utilize iron salts was compromised. The growth defect
of all mutants in low-iron medium was partially rescued by
supplementing 10 μM hemin as an alternative iron source
(Fig. 1b). However, addition of 100 nM mycobactin or 1 μM
carboxymycobactin to the medium containing 10 μM hemin
completely inhibited the growth of the Δrv0455c mutant, in
contrast to that of the mycobactin synthase D (mbtD) mutant,
which lacks mycobactin and carboxymycobactin, but similar to
that of the ΔmmpS4/ΔmmpS5 mutant (Fig. 1c, d). The rescue of
mbtD mutant with mycobactin or hemin is consistent with
reversing an iron-deﬁcient state in M. tuberculosis, but arrested
growth of the Δrv0455c mutant with added siderophores in the
presence of hemin is the hallmark of siderophore poisoning as
previously observed for the siderophore secretion-defective
mutants lacking either mmpS4 and mmpS510,15 or mmpL4 and
mmpL510. In addition, we showed that the siderophore poisoning
phenotype is independent of the ESX-1 system, as shown for the
Δrv0455c mutant directly derived from the virulent M. tuberculosis H37Rv parent strain (ML2700; Table S1) in the growth
assays with mycobactin or carboxymycobactin (Fig. S1e–g).
To determine the minimal inhibitory concentration of exogenous
siderophores for the Δrv0455c mutant, we assessed its viability in
the presence of 20 μM hemin by the microplate Alamar Blue assay
(MABA). Dose-dependent growth inhibition by mycobactin and
carboxymycobactin was observed for the Δrv0455c mutant.
Mycobactin was ~20-fold more toxic (MIC90 ~ 50 nM) for the
Δrv0455c mutant compared to carboxymycobactin (MIC90 ~ 1 μM).
Similar differences were observed previously for the ΔmmpS4/S5
mutant15 (MIC90 ~ 25 nM for mycobactin and 500 nM for
carboxymycobactin) (Fig. 1e, f). Taken together, these experiments
showed that the M. tuberculosis Δrv0455c mutant is hypersensitive
to exogenous mycobactins and carboxymycobactins, indicating
dysfunction or mislocalization of siderophores in the absence of
Rv0455c.
Rv0455c homologs are functionally conserved in mycobacteria.
Rv0455c is annotated as a protein of unknown function containing the DUF5078 domain (Pfam database16). Recognizable
Rv0455c homologs are found only in Mycobacterium and other
closely related genera such as Segniliparus with an outer
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Fig. 1 The M. tuberculosis Δrv0455c mutant is hypersensitive to exogenous siderophores. a–d The indicated M. tuberculosis strains were grown in lowiron 7H9 medium for 5 days to deplete intracellular iron before the growth assays. The initial OD600 of all cultures was 0.01. Growth curves of M.
tuberculosis mc26230 (wt), Δrv0455c (M. tuberculosis ML2203), Δrv0455c::rv0455c (M. tuberculosis ML2205), ΔmmpS4/S5 (M. tuberculosis ML859) and
ΔmbtD (M. tuberculosis ML1600) in (a) self-made low-iron (<0.1 μM Fe3+) 7H9 medium supplemented with (b) 10 μM hemin, (c) 10 μM hemin plus
100 nM Fe-mycobactin (Fe-MBT), and (d) 10 μM hemin plus 1 μM Fe-carboxymycobactin (Fe-cMBT), respectively. Error bars represent standard deviations
from the mean results of biological triplicates (n = 3). e, f The viability of M. tuberculosis wt, ΔmmpS4/S5, Δrv0455c, or Δrv0455c::rv0455c was measured
using the Microplate alamarBlue assay. Cells treated with increasing concentrations of (e) Fe-mycobactin (Fe-MBT) or (f) Fe-carboxymycobactin (FecMBT). Cells were grown in 7H9 medium supplemented with 20 μM hemin. Error bars represent standard deviations from the mean values of biological
triplicates (n = 3). Source data are provided in the Source Data ﬁle.

membrane composed of long-chain mycolic acids (C60-C100)17,
whereas the outer membranes of Gram-negative bacteria consist
mainly of lipopolysaccharides and phospholipids. It is noteworthy
that rv0455c and its homologous genes are always neighboring the
mmpS4-mmpL4 or mmpS5-mmpL5 operons, which encode the
Resistance-Nodulation-Division (RND) family efﬂux pumps (Fig.
S2) involved in siderophore secretion7,10,15. Rv0455c homologs
are highly conserved in mycobacteria (>65% similarity; Fig. S3)
and are encoded by genes classiﬁed as mycobacterial core genes18.
To test whether Rv0455c homologs share the same function, we
expressed the homologous genes msmeg_3494 of M. smegmatis,
ml2380 and b586_19750 of the siderophore-deﬁcient species M.
leprae and M. haemophilum, respectively, in the M. tuberculosis
Δrv0455c deletion mutant using L5 attB integration plasmids
(Table S2). Interestingly, expression of any of these genes completely restored growth of the M. tuberculosis Δrv0455c mutant in
the presence of mycobactin (Fig. 2a), suggesting that Rv0455c
homologs are functionally equivalent in mycobacteria. Further,
we deleted homologous msmeg_3494 gene in the M. smegmatis
ΔfxbA strain, which is deﬁcient in the production of the exochelin
MS siderophores19,20 (Fig. S4). The ΔfxbA/Δmsmeg_3494 mutant
grew like the parent strain in iron-replete medium but had a
growth defect in low-iron 7H9 (1 μM Fe3+) medium and did not
grow in the presence of 1 μM mycobactin, in contrast to the
parent strain (Fig. S5). Expression of rv0455c from the integration
plasmid pML3613 completely restored growth of the ΔfxbA/
Δmsmeg_3494 mutant (Fig. S5), indicating that Rv0455c can

substitute for MSMEG_3494 in M. smegmatis. Collectively, these
results showed that Rv0455c homologs are produced in mycobacteria and that their function in detoxifying mycobactin is
conserved.
Subcellular localization of the Rv0455c protein in M. tuberculosis. Previously, Rv0455c and its homolog were detected in the
culture ﬁltrates of M. tuberculosis H37Rv21 and M. avium subsp.
avium22, respectively, indicating that Rv0455c is secreted by
mycobacteria. Bioinformatic analysis of the Rv0455c sequence
predicts that the amino acids 1–30 constitute a Sec secretion
signal (Fig. S3). Indeed, a truncated gene encoding Rv0455c31–148
(Rv0455cΔSP) with a start codon did not rescue the growth defect
of the M. tuberculosis Δrv0455c mutant in contrast to the intact
rv0455c gene in low-iron medium containing 100 nM mycobactin
(Fig. S6a), indicating that export of Rv0455c is essential for its
function. To speciﬁcally detect Rv0455c, we used recombinant
protein produced in E. coli (see Methods) and generated an
antiserum. Subcellular fractionation of the avirulent M. tuberculosis strain mc26230 (ΔRD1 ΔpanCD) showed a clear separation
of water-soluble versus membrane fractions as indicated by the
marker proteins GlpX and EccB5 (Fig. 2b). Quantitative image
analysis of equivalent samples separated by gel electrophoresis
and detected in Western blots revealed that approximately equal
amounts of Rv0455c protein are in the culture ﬁltrate and cellassociated in M. tuberculosis mc26230 (Fig. S7a). To examine
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Fig. 2 Rv0455c is a conserved 14-kDa exported protein. a Growth curves of the M. tuberculosis Δrv0455c mutant complemented with genes encoding the
Rv0455c homologs MSMEG_3494 of M. smegmatis (M. tuberculosis ML2770), ML2380 of M. leprae (M. tuberculosis ML2294) and B586_19750 of M.
haemophilum (M. tuberculosis ML2295) in 7H9 low iron (<0.1 μM Fe3+) medium supplemented with 100 nM Fe-mycobactin (Fe-MBT). The Δrv0455c
strains complemented with genes encoding Rv0455c (by M. tuberculosis ML2205) and Rv0455cΔSP (Rv0455c31-148; by M. tuberculosis ML2206) were
used as positive and negative controls, respectively. Error bars represent standard deviations from the mean results of biological triplicates (n = 3).
b Subcellular localization of Rv0455c in M. tuberculosis mc26230. Immunoblot analysis of the whole-cell lysate (WCL), the membrane (Mem) and watersoluble fractions (Sol), and of the culture ﬁltrate (CF). The culture ﬁltrate was concentrated 200-fold. Five microliter of each fraction taken from the WCL,
Mem2, Sol2, and CF fractions were loaded into 8% SDS-PAGE gels for Western blots. The Rv0455c proteins were detected with an Rv0455c-speciﬁc
antiserum. EccB5, GlpX, and Ag85 served as indicator proteins for the membrane-associated proteins, soluble proteins, and secreted proteins, respectively.
Data were obtained from at least two independent experiments and representative images are shown. c Growth curves of the M. tuberculosis Δrv0455c
mutant (strain ML2203, Table S1) complemented with genes encoding Twin-Strep tagged Rv0455c (ML2298), StrepII-His8 tagged MSMEG_3494
(ML2293), Rv0455c-MBP (ML2299) and Rv0455c-TM3 (ML2778), respectively, in 7H9 low-iron medium (<0.1 μM Fe3+) supplemented with 100 nM Femycobactin (Fe-MBT). Error bars represent standard deviations from the mean results of biological triplicates (n = 3). Source data are provided in the
Source Data ﬁle.

whether the ESX-1 system plays a role in this phenotype, we
repeated the subcellular fractionation experiments in M. tuberculosis mc26206 (ΔleuCD ΔpanCD) containing all ESX systems
(Fig. S7b). Similarly, ~40% of Rv0455c was detected in the culture
ﬁltrate of M. tuberculosis mc26206 (Fig. S7c). The phenomenon
that proteins with functions in the periplasm are also secreted
into the culture ﬁltrate is not uncommon for M. tuberculosis. For
example, the antigen 85 proteins are mycolyltransferases with
their only known functions in the periplasm23,24, are also found
in large quantities in the culture ﬁltrate25. In our experiment,
~30% of antigen 85 was detected in the culture ﬁltrate (Fig. 2b).
Rv0455c performs its essential function in the periplasm of M.
tuberculosis. To examine whether secretion of Rv0455c is
required for M. tuberculosis to grow in the presence of siderophores, we constructed a fusion protein of Rv0455c with the
C-terminal maltose-binding protein MBP (Table S2). We
assumed that the large Rv0455c-MBP fusion protein (~60 kDa)
would be trapped in the periplasm of M. tuberculosis, in contrast
to the small Rv0455c protein (14 kDa). However, a growth assay
in M. tuberculosis showed that expression of the rv0455c-mbp
fusion gene from integration plasmid pML4285 completely rescued the Δrv0455c mutant in low-iron medium with 100 nM
mycobactin (Fig. 2c), indicating that the Rv0455c-MBP fusion
protein is functional in M. tuberculosis. Surprisingly, we still
detected ~25% of the Rv0455c-MBP fusion protein in the culture
ﬁltrate compared to the M. tuberculosis mc26230 strain producing
natural Rv0455c, but signiﬁcantly more Rv0455c-MBP was cellassociated (Fig. 2b). Next, we constructed an Rv0455c variant
containing three C-terminal transmembrane helices to anchor the
protein to the membrane and prevent its secretion across the
outer membrane. Indeed, subcellular localization experiments
showed that the Rv0455c protein with transmembrane helices
(Rv0455c-TM3) is mainly localized in the membrane fraction but
is not detectable in the culture ﬁltrate (Fig. 2b). Importantly,
4

expression of the rv0455c-TM3 fusion gene using the integration
plasmid pML4299 (Table S2) completely rescued the Δrv0455c
mutant in low-iron medium with 100 nM mycobactin (Fig. 2c) or
1 μM carboxymycobactin (Fig. S6b), demonstrating that (i)
membrane-anchored Rv0455c is functional, (ii) that secretion of
Rv0455c into the extracellular medium is not required for the
function of Rv0455c, and (iii) that the function of Rv0455c is
identical for carboxymycobactin and mycobactin. Furthermore,
we found that variation of the linker length from 3 aa to 30 aa
between Rv0455c and the C-terminal transmembrane helices
does not signiﬁcantly affect the function of Rv0455c (Fig. S6c). In
addition, adding the puriﬁed proteins, 1 μM Rv0455c31-148
(Rv0455cΔSP) or 2 μM MSMEG_349433–153, into the liquid
medium failed to restore the growth of the Δrv0455c mutant in
the presence of mycobactin (Fig. S6d), suggesting that
MSMEG_3494 or Rv0455c does not function outside of the M.
tuberculosis cells. Collectively, these experiments demonstrated
that Rv0455c performs an essential siderophore-related function
in the periplasm of M. tuberculosis.
Rv0455c is required for siderophore secretion in M. tuberculosis.
Since the toxicity of mycobactins or carboxymycobactins for the
M. tuberculosis Δrv0455c resembled the siderophore-poisoning
phenotype previously observed for the siderophore secretiondefective M. tuberculosis ΔmmpS4/ΔmmpS5 mutant15 (Fig. 1c–f),
we hypothesized that Rv0455c is required for siderophore secretion. To examine this hypothesis, mycobactins and carboxymycobactins were radioactively labeled in the parent strain M.
tuberculosis mc26230, the Δrv0455c, ΔmbtD (no siderophore
synthesis5) and ΔmmpS4/mmpS5 mutants (no siderophore
secretion7) by using the radiolabeled precursor salicylic acid as
previously described7. All strains were grown in self-made low-iron
7H9 medium containing 1 μM ammonium ferric citrate and 16 μM
14C-salicylic acid for 10 days. The cultures of the ΔmbtD mutant
were supplemented with 10 μM hemin to enable growth. The
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Fig. 3 Rv0455c is required for siderophore secretion by M. tuberculosis.
Thin-layer chromatography of chloroform-extracted siderophores from the
culture ﬁltrates of the M. tuberculosis mc26230 parent strain, the
siderophore biosynthetic mutant ΔmbtD, the siderophore secretiondefective mutant ΔmmpS4/mmpS5, the Δrv0455c mutant and the Δrv0455c
mutant complemented with integrated rv0455c and rv0455c-TM3
expression vectors. The siderophores were labeled with [7-14C]-salicylic
acid (SA), which was loaded on the silica gel plate as a control together
with 55Fe-carboxymycobactin (cMBT) and 55Fe-mycobactin (MBT). A
mixture of ethanol/cyclohexane/water/ethyl acetate/acetic acid with the
volume ratios of 5:25:2.5:35:542 was used as a solvent. The loaded samples
were normalized to their OD600 at the time of harvest of the bacterial
cultures. Data were obtained from at least two independent experiments
and representative images are shown. Source data are provided in the
Source Data ﬁle.

siderophores were extracted with chloroform from the culture
ﬁltrates and analyzed by thin-layer chromatography (TLC). As
expected, M. tuberculosis mc26230 secreted mycobactins and carboxymycobactins, which were identiﬁed in the TLC by the absence
of the respective signals in the siderophore-deﬁcient ΔmbtD
mutant and by the 55Fe-MBT and 55Fe-cMBT controls (Fig. 3).
Quantitative image analysis revealed that mycobactins in the culture ﬁltrate are the predominant siderophores with a two-fold
excess over carboxymycobactins. Importantly, the quantities of
both secreted mycobactins and carboxymycobactins were reduced
in the Δrv0455c mutant to 4.9% and 9.6%, respectively, compared
to the parent M. tuberculosis mc26230 strain (Fig. 3). This result is
very similar to that obtained for the ΔmmpS4/S5 mutant, which
showed a reduction of mycobactin and carboxymycobactin levels
to 1.4% and 0.7%, respectively, compared to the parent strain
(Fig. 3). Complementation of the Δrv0455c mutant by wild-type
Rv0455c and the membrane-anchored Rv0455c (Rv0455c-TM3)
fully restored siderophore secretion to wild-type levels (Fig. 3).
These results demonstrated that Rv0455c is required for secretion
of both mycobactins and carboxymycobactins by M. tuberculosis.

The chemical diversity and structures of siderophores produced by M. tuberculosis are not altered by deletion of the
rv0455c gene. To examine whether siderophore synthesis is
altered in the Δrv0455c mutant, the lipidomes of M. tuberculosis
mc26230, the Δrv0455c mutant and the complemented mutant

ARTICLE

were analyzed. To obtain siderophore quantities sufﬁcient for
lipidomics, all strains were grown in 15-fold larger volumes of
low-iron 7H9 medium compared to the TLC experiments. Lipids
were extracted with chloroform/methanol from the cell pellets
and analyzed as previously described15. Mycobactins typically
have long-chain fatty acids (C18-C20), whereas carboxymycobactins are rendered more soluble by their short-chain
(C5-C12) and negatively charged dicarboxylates26. Both siderophores also exhibit different amino acid modiﬁcations and
altered hydroxylation and saturation states, which affect their
biological activities12,27 (Fig. 4a). We generated molecular species
by collision-induced dissociation mass spectrometry (CID-MS)
and tracked them based on mass differences of the mycobactic
acid unit (Fig. S8). This fragment reveals the saturation state of
the fatty acids and lengths of carboxymycobactins (C5-C12) and
mycobactins (C18-C20) (Fig. 4b, c). This method also generates a
fragment ion, which distinguishes methylserine and serine
modiﬁcations (Fig. S8c). High-performance liquid chromatography combined with time-of-ﬂight mass spectrometry (HPLCTOF-MS) revealed the presence of all major ferri-siderophore
species in lipid extracts of both the parent M. tuberculosis
mc26230 strain and the Δrv0455c mutant (Fig. 4b, c) demonstrating that the loss of Rv0455c does not change the hydroxylation state, methylserine use and fatty acyl length, and
saturation of the detected siderophores. Importantly, lipidomics
revealed an identical chemical diversity of the siderophores produced by the parent strain M. tuberculosis and the Δrv0455c
mutant, strongly indicating that the loss of Rv0455c does not alter
the siderophore synthesis in M. tuberculosis. The signals of the
total cell-associated mycobactins in the Δrv0455c mutant were
reduced by ~40% compared to the parent M. tuberculosis
mc26230 strain, while the total cell-associated carboxymycobactins were increased by four-fold in the Δrv0455c mutant
(Fig. 4d). Importantly, similar quantitative changes of the cellassociated siderophores were observed in previous lipidomics
experiments for the siderophore secretion-deﬁcient ΔmmpS4/S5
mutant and were explained by the observed intracellular accumulation
of
the
normally
secreted
hydrophilic
carboxymycobactins15. In conclusion, the lipidomics experiments
demonstrate that the lack of Rv0455c does not change the chemical diversity and structures of the siderophores synthesized by
M. tuberculosis. Thus, the observed phenotypes of the Δrv0455c
mutant are indeed caused by the impaired secretion of siderophores and the subsequent downregulation of siderophore
production in M. tuberculosis.
The DUF5078 domain of Rv0455c exhibits a novel structure.
To determine the structure of Rv0455c, we produced the
Rv0455c31-148 (Rv0455cΔSP) protein with a C-terminal hexahistidine-tag. However, this protein accumulated in inclusion
bodies. Based on the observation that mutation of either of the two
conserved cysteines (Fig. S3) in Rv0455c completely abolished the
function of Rv0455c (Fig. S6e), we hypothesized that these cysteines
form an intramolecular disulﬁde bond. To enable disulﬁde bond
formation in the periplasm, we fused the Rv0455c31-148
(Rv0455cΔSP) protein with the signal peptide of OmpF, an
exported porin of E. coli. Export into the E. coli periplasm signiﬁcantly increased the amount of soluble Rv0455c protein, but the
puriﬁed protein rapidly aggregated at concentrations exceeding
50 μM. To circumvent these difﬁculties, we examined the close
homolog MSMEG_3494 of M. smegmatis, which shares 66%
similar amino acids with Rv0455c (Fig. S3) and has the same
function (Fig. 2a). Production of MSMEG_349433–153 with a
C-terminal StrepII-His8 tag in the periplasm of E. coli yielded a
large amount of soluble protein (Fig. S9a). Growth experiments
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Fig. 4 Siderophore proﬁle of the M. tuberculosis Δrv0455c mutant. Whole-cell lipid extracts of M. tuberculosis mc26230, the Δrv0455c mutant, and the
Δrv0455c mutant complemented with an integrated rv0455c expression vector were analyzed by lipidomics using high-performance liquid chromatography
and mass spectroscopy. a Chemical structure of the core of M. tuberculosis siderophores. R1: H or CH3 represent the serine (S) or methylserine (M) form,
respectively. R2: alkyl chains. The mean intensity values for molecular events are shown for a subset of carboxymycobactin isoforms (b) and mycobactin
isoforms (c). The indicated fatty acid chain lengths (number of carbons) and the number of double bonds corresponding to mono- or di-carboxyl units
assume the peptide structure shown in (a), which according to prior analyses is the dominant form12,55. The monodeoxy-mycobactins and monodeoxycarboxymycobactins are indicated with a hash tag (#). d Total mycobactin and total carboxymycobactin counts in wt M. tuberculosis (blue), the Δrv0455c
mutant ML2203 (red), and the complemented strain ML2205 (gray). Data are mean ± s.d. of four biological replicates. Asterisks indicate signiﬁcant
differences (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by one-way ANOVA with Tukey’s test) compared with wt M. tuberculosis. Source data are
provided in the Source Data ﬁle.

with M. tuberculosis using the integrative expression vectors
pML4279 and pML4284 (Table S2) showed that MSMEG_3494
with a C-terminal StrepII-His8 tag and Rv0455c with a C-terminal
Twin-Strep tag fully restored the growth of the M. tuberculosis
Δrv0455c mutant in medium with mycobactin (Fig. 2c), indicating
that small C-terminal tags do not affect the functions of
either MSMEG_3494 or Rv0455c in M. tuberculosis. The
MSMEG_349433–153 protein was puriﬁed by Ni(II)-afﬁnity chromatography, and its afﬁnity tag was removed by enterokinase (Fig.
S9b). The MSMEG_349433–153 protein was further puriﬁed by size
exclusion chromatography yielding a single peak with an estimated
6

molecular weight of 15 kDa consistent with its predicted value
indicating that the MSMEG_349433–153 protein is a monomer (Fig.
S9a). The MSMEG_349433–153 protein was soluble at concentration
of 1 mM. The three-dimensional structure of MSMEG_349433–153
was solved by X-ray crystallography and reﬁned to 2.1 Å (Table S4).
As no structures of MSMEG_349433–153 homologs are known,
experimental methods were required to determine the phases
instead of molecular replacement methods. To this end, the crystal
was soaked with sodium bromide, and the phases were determined
by multiwave anomalous dispersion (MAD) using the bromide
ions as the source of anomalous scattering. The unit cell contained
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Fig. 5 Structure of the Rv0455c homolog MSMEG_3494. a Topology of MSMEG_349433-153. N- and C-termini are indicated, helices are depicted as black
tubes numbered from N-terminus to C-terminus (α1-α9; other numbers represent the sequence number for the ﬁrst and last residue of the helix). The
disulﬁde bond between C49 and C140 is indicated with a red dashed line. Loops are not drawn to scale. b–d Cartoon depictions of MSMEG_349433-153
colored by amino acid sequence from the N-terminus (blue) to the C-terminus (red). The disulﬁde bond between C49 and C140 is shown using stick
representation and colored yellow. Spatial relationship between the orientations in b–d are reﬂected by the rotational arrows between each image. e Colors
reﬂect the conservation of amino acids across the 150 closest members of DUF5078 to MSMEG_3494. Purple indicates high conservation, white indicates
moderate conservation, and teal indicates a lack of conservation. Patches 1 and 2 are highlighted within black dashed ellipses. The orientation is the same
as in (c). f Surface depiction of the electrostatic surface potential from -5 kT/e (red) to +5 kT/e (blue). Patches 1 and 2 are highlighted within black dashed
ellipses. The orientation is the same as in (c).

two molecules of MSMEG_349433–153 and 11 bromide ions with
~42% of the volume being occupied by solvent molecules.
MSMEG_349433–153 adopts a novel structure consisting of a helical
bundle with four single turn α-helices and ﬁve longer α-helices
(Figs. 4a–d, S10a). A disulﬁde bond between C49 and C140 connects the N-terminus of helix 2 and the C-terminus of helix 8,
establishing a cinch-like topology (Fig. 5a). These two cysteines are
conserved across all members of the DUF5078 homology (Fig. S3),
indicating that the disulﬁde bond plays an important role in
structure stabilization. In addition, we found that other evolutionarily conserved amino acids clustered predominantly in two

distinct surface-exposed patches (Figs. 4e, S10b, c): the interface
between the ﬂexible N-terminus and helix 5 (patch 1), and the
interfacial region of helices 2, 3, 7, and 8, (patch 2). Analysis of the
electrostatic potential map of MSMEG_349433–153 revealed a highly
electropositive surface for patch 2, which may form an interaction
interface accommodating proteins or molecules with negatively
charged domains or moieties (Figs. 4f, S10d). Patch 1 did not
display a signiﬁcant number of charges, but the residues constituting patch 1 exhibited large B-factors indicating conformational ﬂexibility and the potential for adopting structures in
solution different from that in the crystal lattice (Fig. S10e).
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Fig. 6 Rv0455c is a virulence factor of M. tuberculosis in mice. C57BL/6 mice infected with the WT M. tuberculosis parent strain (ML2710), the Δrv0455c
mutant (ML2711), and the complemented strain (ML2701). Colony-forming unit (CFU) counts in the lungs (a) and spleens (b) of mice infected with the
indicated strains. Data represent the mean ± s.d. of four mice per time point. Note that one mouse infected with Δrv0455c mutant was euthanized on day
51 due to an unrelated illness. Source data are provided in the Source Data ﬁle. c Gross pathology scans of left lung lobes of mice harvested on day 70 after
infection. d Histopathology of lungs of mice harvested on day 70 after infection. The scale bar is 1 mm. Data were obtained from two independent
experiments and representative images are shown.

The MSMEG_3494 protein does not interact with carboxymycobactins in vitro. It is unclear how Rv0455c mediates
siderophore secretion. It is possible that periplasmic Rv0455c has
an essential structural role in the siderophore secretion system of
M. tuberculosis, e.g., as an adapter protein as AcrA in the tripartite efﬂux system of E. coli28. An alternative hypothesis is that
Rv0455c acts as a periplasmic carrier of siderophores and contributes to the transport of siderophores to the outer membrane.
Such a function would require siderophore binding. To test
whether Rv0455c homologs bind siderophores, we conducted 2D
1H-15N HSQC NMR titrations and examined the chemical shift
perturbations of 15N-labeled MSMEG_349433–153 in the presence
of deferrated carboxymycobactin S from M. smegmatis. No signiﬁcant difference in the spectra was observed (Fig. S11). To
examine the unlikely possibility that Rv0455c might bind ironloaded carboxymycobactin, we added gallium (III), a commonly
used substitute to avoid interference from paramagnetic iron
(III)29, at a ratio of 1:1 to deferrated carboxymycobactin. However, we did not observe any changes of the chemical shift perturbations of the 15N-labeled MSMEG_349433–153 protein. These
experiments indicate that the recombinant MSMEG_3494 protein
does not interact with carboxymycobactin in vitro.
Rv0455c is required for full virulence of M. tuberculosis in
mice. To assess the role of Rv0455c for virulence of M. tuberculosis,
C57BL/6 mice were infected with low dose aerosols containing the
M. tuberculosis H37Rv parent strain (ML2710), the Δrv0455c
mutant (ML2711) and the complemented strain (ML2701). Loss of
the rv0455c gene severely compromised the ability of M. tuberculosis to proliferate in lungs and in spleens as the number of viable
bacteria decreased by 140- and 2200-fold, respectively, compared
to the parent M. tuberculosis H37Rv on day 28 post infection
(Fig. 6a, b). The differences were reduced to 6- and 40-fold in lungs
and spleens, respectively, on day 70 post infection (Fig. 6a, b). The
8

expression of rv0455c from the mycobacteriophage L5 integration
plasmid pML3613 completely restored the ability of the Δrv0455c
mutant to proliferate in lungs and spleens. These results demonstrate that Rv0455c is necessary for M. tuberculosis to establish a
lung infection in mice, especially in the early stage. Gross pathological examination and histological assessment on lungs of mice
infected with either the parent strain M. tuberculosis H37Rv or the
rv0455c complemented strain exhibited extensive lesions and displayed signiﬁcant lymphocytic inﬁltrates on day 70 post infection
(Fig. 6c, d). In contrast, lungs of the mice infected with the
Δrv0455c deletion mutant showed many fewer lesions or much
weaker lymphocytic inﬁltrates (Fig. 6c, d). In conclusion, the
infection experiments showed that Rv0455c is required for full
virulence of M. tuberculosis in mice.
Discussion
Rv0455c is essential for siderophore secretion in M. tuberculosis.
Rv0455c is one of the 219 mycobacterial core proteins, which are
shared between M. tuberculosis and M. leprae, have no homologs
outside of mycobacteria and are implicated to be involved in
pathways unique to mycobacteria18. In this study, we showed that
siderophore secretion by M. tuberculosis is strongly reduced in the
rv0455c deletion mutant, while the chemical diversity and structures of the detected siderophores are identical to that of wild-type
M. tuberculosis. These results and other phenotypes of the rv0455c
deletion mutant such as growth defect in low-iron medium even in
the presence of heme and toxicity of siderophores, are very similar
to those observed for the M. tuberculosis siderophore secretion
mutant lacking the MmpS4 and MmpS5 proteins7,15. Mechanistically, these phenotypes are explained by the accumulation of
both exogenous mycobactins and carboxymycobactins in the
ΔmmpS4/mmpS5 mutant compared with the parent M. tuberculosis strain as observed previously in uptake experiments15. As a
consequence, siderophore secretion mutants reduce siderophore
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production to avoid the toxic accumulation of siderophores inside
the cells, as observed also for enterobactin secretion-deﬁcient E. coli
mutants13,30. This mechanism might involve the inhibition of the
(carboxy)mycobactin biosynthesis complex assembly as proposed
for the glycopeptidolipid secretion-deﬁcient M. smegmatis mmpS4
deletion mutant31. The toxicity of external siderophores for M.
tuberculosis mutants with a defective siderophore secretion system
in the presence of heme was termed siderophore poisoning15 and is
based on siderophore recycling: the repetitive cycle of uptake of
iron-loaded siderophores, removal of iron from siderophores by a
reductive mechanism and secretion of empty siderophores15. Thus,
all phenotypes of the M. tuberculosis rv0455c deletion mutant are
consistent with impaired siderophore secretion and recycling.
The proteins which are targeted by empty siderophores
trapped within the M. tuberculosis cell are unknown, but may
include the essential iron-sulfur cluster proteins involved in
bacterial energy production, such as the NADH dehydrogenase
complex I32. The potential of the mainly membrane-associated,
hydrophobic MBTs6 to target membrane proteins may explain
the 10-20-fold increased toxicity of mycobactin compared to
cMBTs for M. tuberculosis Δrv0455c mutant (Fig. 1e, f) and for
other siderophore secretion mutants of M. tuberculosis15. Taken
together, in this study, we identiﬁed Rv0455c as the ﬁrst single
protein essential for siderophore secretion by M. tuberculosis. It
remains unclear how it interacts with the two siderophore export
pumps consisting of the MmpL4/MmpS4 and MmpL5/MmpS5
proteins7,15.
Rv0455c is essential for virulence of M. tuberculosis in mice. In
this study, we showed that Rv0455c is the ﬁrst single protein
involved in siderophore secretion which is required for virulence
of M. tuberculosis in mice. While the ΔmmpS4/mmpS5 mutant
also has a virulence defect7, two genes need to be deleted since the
MmpS4/MmpL4 and MmpS5/MmpL5 efﬂux systems have similar functions in siderophore secretion. Although these proteins
function in the same pathway, interesting differences in their
roles in virulence were evident. While the bacterial burden in the
lungs of mice 28 days after infection with the M. tuberculosis
Δrv0455c deletion mutant was 140-fold reduced compared to wt
M. tuberculosis, it was >10,000 fold reduced for the mmpS4/
mmpS5 deletion mutant compared to the parent M. tuberculosis
H37Rv strain7. The larger attenuation of the mmpS4/mmpS5
double deletion mutant is consistent with the increased toxicity of
mycobactin compared to the rv0455c deletion mutant (Fig. 1e),
indicating that self-poisoning of the M. tuberculosis mutants with
impaired siderophore secretion is the likely cause of their virulence loss. Our results also indicate that the rv0455c deletion
mutant is more permissive for residual siderophore secretion than
the mmpS4/mmpS5 deletion mutant. This conclusion is consistent
with the slow but signiﬁcant replication of the M. tuberculosis
rv0455c deletion mutant in the lungs of mice (Fig. 6a, c), while the
mmpS4/mmpS5 deletion mutant did not replicate at all and
showed no signs of lung pathology7 in contrast to M. tuberculosis
Δrv0455c. Taken together, our studies provide a proof of principle
that single proteins required for siderophore secretion exist and
further validate siderophore secretion as a suitable target for novel
tuberculosis drugs.
Structure and function of Rv0455c. Our ﬁnding that Rv0455c is
secreted by M. tuberculosis is in accordance with previous proteomic analyses21,33, but was difﬁcult to reconcile with its
essential function in siderophore secretion. One possible
mechanism is that mature Rv0455c binds empty siderophores in
the periplasm and subsequently transports siderophores across
the outer membrane. Similar mechanisms were reported for the
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transport of mycobacterial lipids such as phthiocerol dimycocerosates (PDIM) and triacylglycerides (TAG) by the periplasmic
lipoproteins LppX34 and LprG35, respectively, to the outer
membrane. However, the lack of chemical shift perturbations by
NMR spectroscopy indicated that the close Rv0455c homolog
MSMEG_3494 does not interact with carboxymycobactin. This
ﬁnding is consistent with the absence of a deep cleft in the crystal
structure of MSMEG_3494 (Fig. S10) and in the identical structure of Rv0455c (Fig. S12) predicted by AlphaFold36. Deep
binding pockets are commonly found in siderophore-binding
proteins (Fig. S13) and in the lipid-binding LppX and LprG
proteins (Fig. S14). Our structural analysis showed that
MSMEG_3494 and Rv0455c consist of nine α-helices, while LprG
and LppX consist of mainly β-sheets (Fig. S14a, b) and possess
large and hydrophobic cavities to accommodate their lipid substrates (Fig. S14c, d). A narrow and deep hydrophobic groove
capable of binding mycobactin was also observed for CD1a (Fig.
S15), a protein which is part of the antigen-presenting CD1
complex in mammalian cells37. These structural comparisons
show that the DUF5078 family proteins are different from the
LprAFG family or other proteins and may not directly bind small
lipophilic molecules such as mycobactin and carboxymycobactin.
However, we cannot exclude that our experimental conditions
were not suitable for carboxymycobactin binding by
MSMEG_3494 or that MSMEG_3494 might require another
protein or protein modiﬁcations for siderophore binding. For
example, it is conceivable that Rv0455c is capable of carboxymycobactin binding after folding in the periplasm and then
switches to a closed conﬁguration with the formation of the
essential disulﬁde bond. Similar protein dynamics have been
reported for azurin, a copper-binding protein from Pseudomonas
aeruginosa38.
On the other hand, the observation that membrane-anchored
Rv0455c-TM3 is fully functional in the Δrv0455c mutant rules out
a function of secreted Rv0455c in siderophore secretion. Instead,
these results support an alternative mechanism in which Rv0455c
plays an important structural role in the siderophore secretion
system of M. tuberculosis, possibly by acting as an essential
accessory protein to maintain the activity of the MmpL efﬂux
systems or by connecting the inner membrane siderophore
exporters MmpL4/MmpS4 and MmpL5/MmpS57 with a putative
outer membrane channel (Fig. 7). The hypothesis of a functional
connection of Rv0455c with the siderophore efﬂux systems is
supported by the close proximity of the rv0455c orthologous
genes to mmpL4 or mmpL5 in all mycobacterial species (Fig. S2)
and by our structural analysis revealing two surface patches,
which might provide docking interfaces for other proteins
(Fig. 5e, f). An example of such a mechanism is the AcrBAcrA-TolC tripartite efﬂux system, which mediates siderophore
secretion in many Gram-negative bacteria. In E. coli the inner
membrane RND efﬂux pump AcrB and outer membrane channel
TolC are connected by the periplasmic adapter protein AcrA13.
The multi-functionality of the AcrB-AcrA-TolC tripartite efﬂux
system in siderophore secretion and drug efﬂux would also
explain why even the siderophore-deﬁcient species M. leprae and
M. haemophilum still possess the fully functional Rv0455c
homologs ML2380 and B586_19750.
Our study identiﬁes the essential function of the mycobacterial
core protein Rv0455c in siderophore secretion and in virulence of
M. tuberculosis in mice. Rv0455c is exported across the inner
membrane by the SecYEG translocon, and likely plays a structural
role in siderophore transport to the outer membrane (Fig. 7). This
study presents a major step forward in understanding the M.
tuberculosis siderophore secretion system, whose proteins have no
similarities to other bacterial siderophore secretion
systems14,39–41. Furthermore, we identify siderophore poisoning

NATURE COMMUNICATIONS | (2022)13:2255 | https://doi.org/10.1038/s41467-022-29873-6 | www.nature.com/naturecommunications

9

ARTICLE

NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-022-29873-6

created by the cre expressing vector pML2714. Then, msmeg_3494 deletion in the
ML2249 strain was done with the same strategy by a suicide vector pML3618. The
ΔfxbA::loxP Δmsmeg_3494::hygr (ML2275) double mutant was validated by PCR
(Fig. S4c, d). A series of expression vectors of rv0455c or msmeg_3494 were
transformed into either M. tuberculosis Δrv0455c (ML2203) or Msm ΔfxbA
Δmsmeg_3494 (ML2275) strains to integrate into the chromosomal L5 attB sites for
generating the complementation strains (Table S1). All the mutants are listed in
Table S1, and the deletion and expression vectors are listed in Table S2.
Growth assays. The M. tuberculosis mc26230 strain (as wt) and its derivative
strains were pre-grown in 7H9/hemin medium (supplements: 0.5% glycerol,
24 μg/mL pantothenate, 0.2% casamino acids and 0.01% tyloxapol) until the OD600
reached ~1.0. Afterward, the cells were grown in self-made low-iron 7H9 medium
(<0.1 μM Fe3+ as determined by ICP-MS) containing the supplements for 5–7 days
to deplete intracellular iron sources. The iron-depleted cells were inoculated into
10 mL of low-iron 7H9 medium (containing the supplements) at an initial OD600
of 0.01 with different iron sources: 10 μM hemin; 10 μM hemin plus 100 nM
Fe- mycobactin; 10 μM hemin plus 1 μM Fe-carboxymycobactin, respectively. The
OD600 of the cultures were determined every 24 or 48 h. All experiments were done
in triplicate.

Fig. 7 Model of siderophore secretion and recycling in M. tuberculosis.
Iron-loaded siderophores are taken up on the cell surface by a putative
siderophore receptor and then transferred to the inner membrane importer
IrtAB56–58. The transport across the periplasmic space is probably
mediated by proteins of unknown identity. Then, ferric siderophores are
taken up by IrtAB across the inner membrane (IM). During this process,
iron (III) is reduced and dissociates from the siderophores. Deferrated
siderophores are exported again, along with the export of de novo
synthesized siderophores, by a process dependent on the MmpL4/S4 and
MmpL5/S5 efﬂux systems7,10,15. The Rv0455c pre-protein is translocated
across the inner membrane via SecA1 secretion system. The mature, watersoluble Rv0455c protein is located in the periplasm and is essential for
secretion of carboxymycobactin (cMBT), possibly by interaction with the
MmpL4/5-MmpS4/5 systems. Transport of siderophores across the outer
membrane (OM) requires at least one hitherto unknown protein.

as an important mechanism of the large virulence loss of the M.
tuberculosis mutant lacking the rv0455c gene, validating siderophore secretion as a drug target and revealing a new
mechanism for putative tuberculosis drugs.
Methods
Bacterial strains, reagents, media, and growth conditions. All the strains used
in this study are listed in the Table S1. The avirulent M. tuberculosis strain mc26230
(H37Rv ΔRD1 ΔpanCD) and its derivative strains were grown in Middlebrook 7H9
broth (Difco) supplemented with 10% ADS (50 g/L bovine albumin, 20 g/L dextrose, 8.5 g/L NaCl), 0.5% glycerol, 24 μg/mL pantothenate, 0.2% casamino acids
and 0.01% tyloxapol. The virulent M. tuberculosis H37Rv and its derivative strains
were grown in Middlebrook 7H9 broth (Difco) supplemented with 10% OADC
(Middlebrook oleic acid-albumin-dextrose-catalase), 0.5% glycerol, 0.2% casamino
acids and 0.01% tyloxapol. Escherichia coli strains were grown in either LB medium
or M9 minimal medium containing appropriate antibiotics at 37 °C with shaking at
200 rpm. The following antibiotics were used when required: kanamycin (Kan) at
30 μg/mL for mycobacteria or E. coli, and hygromycin (Hyg) at 200 μg/mL for E.
coli, and 50 μg/mL for mycobacteria. Puriﬁed iron-free and iron-loaded carboxymycobactins (cMBTs) from M. smegmatis were purchased from EMC Microcollections (Germany). Iron-loaded mycobactin (MBTs) was puriﬁed from M.
smegmatis by chromatography42 and was provided by Dr. Colin Ratledge. All other
chemicals were purchased from Sigma at the highest quality available.
Construction of M. tuberculosis gene deletion mutants and complementation
strains. The rv0455c, fxbA, and msmeg_3494 genes deletion were performed by
homologous recombination strategy using previous procedure43. The parent M.
tuberculosis mc26230 strain harboring the rv0455c deletion vector pML3694 were
grown on the selective 7H10 plates containing 10% ADS, 0.5% glycerol, 24 μg/mL
pantothenate, 0.2% casamino acids, 20 μM hemin, 2% (w/v) sucrose and 50 μg/mL
hygromycin. The plates were cultured at 40 °C for 4 weeks to select for the double
cross-over (DCO) colonies which were then validated by PCR (Fig. S1a, b). The
rv0455c gene deletion in the virulent strain M. tuberculosis H37Rv was done by the
same protocol and was validated by PCR (Fig. S1a, c). For fxbA deletion, a suicide
vector pML3655 was transformed into M. smegmatis mc2155 to create the single
cross-over (SCO) colonies on 7H10 plates supplemented with 50 μg/mL hygromycin. Then, 2% sucrose was used to select for the DCO colonies, which were then
validated by PCR (Fig. S4a, b). The unmarked strain ΔfxbA::loxP (ML2249) was
10

Siderophore toxicity assays. The siderophore toxicity assays were performed as
previously described15. Puriﬁed mycobactins (Fe-MBTs) and carboxymycobactins
(Fe-cMBTs) dissolved in ethanol were serially diluted using 7H9 medium with
supplements (10% ADS, 20 μM Hemin, 0.5% glycerol, 24 μg/mL pantothenate,
0.2% casamino acids and 0.01% tyloxapol) in 96-well plates in 100 μL volumes by
triplicate. The pre-grown M. tuberculosis cultures using 7H9 medium containing
the supplements with an OD600 of ~0.5 were diluted to the OD600 of 0.02. One
hundred microliter volumes of each cell suspension were distributed to all wells
receiving cells. Plates were incubated for 5–6 days at 37 °C with 230 rpm shaking on
a microplate mixer. Forty μL of alamarBlue working solution (alamarBlue:10%
Tween-80 = 1:1) was added and the plates were incubated at 37 °C with 230 rpm
for 8 h. The ﬂuorescence of each well was analyzed using a Biotek Synergy HT plate
reader with a 530 nm excitation and a 590 nm emission ﬁlter. The growth inhibition assays % viability was determined by subtracting background ﬂuorescence
from un-inoculated samples followed by normalizing ﬂuorescence values to samples that did not receive any treatment. Fluorescence values from untreated cells
were set at 100%.
Thin-layer chromatography of siderophores from M. tuberculosis culture ﬁltrates. Radiolabeling of siderophores was performed in a similar manner as previously described with modiﬁcations7. The M. tuberculosis strains mc26230 (parent
strain), ΔmbtD (ML1600), ΔmmpS4/S5 (ML859), Δrv0455c (ML2203),
Δrv0455c::rv0455c (ML2205) and Δrv0455c::rv0455c-TM3 (ML2778) (Table S1)
were pre-grown in 10 mL Middlebrook 7H9 medium containing 10 μM hemin,
10% ADS, 0.2% glycerol, 24 μg/mL pantothenate, 0.2% casamino acids and 0.02%
tyloxapol to OD600 of ~1.5. Then, the cells were washed with phosphate buffered
saline (PBS; 137 mM NaCl, 2.7 mM KCl, 2 mM KH2PO4, 8 mM Na2HPO4, pH 7.4)
and transferred to 20 mL self-made 7H9 medium without added iron (total iron
concentration <0.1 μM as determined by inductively coupled plasma mass
spectrometry10) containing supplements (0.2% glycerol, 24 μg/mL pantothenate,
0.2% casamino acids and 0.02% tyloxapol) for two more days to deplete intracellular iron stores. Subsequently, the iron-depleted M. tuberculosis strains were
inoculated into 8 mL of low-iron 7H9 medium containing the supplements as
described above with 1 μM ammonium ferric citrate and 16 μM [7-14C]-salicylic
acid (0.75 μCi/mL, American Radiolabeled Chemicals) were grown for 10 days with
shaking at 37 oC. The cultures of the ΔmbtD mutant were supplemented with
10 μM hemin to enable growth. The cultures of the WT, the rv0455c complementation strains, and the ΔmbtD mutant reached OD600 of 2.5 from an initial
OD600 of 0.15. The cultures of the ΔmmpS4/S5 and the Δrv0455c mutants reached
OD600 of 1.3 and 2.2, respectively, from an initial OD600 of 0.6. The cultures were
centrifuged for 10 min at 5000 × g and the supernatants were collected. The
supernatants were ﬁltered through a 0.22 μm ﬁlter (Millipore). Ferric chloride
(100 mM FeCl3 in ethanol) was added at a ﬁnal concentration of 0.6 mM to
saturate siderophores in the supernatants with iron at room temperature for 1 h.
Then, the supernatants were extracted twice with 5 mL chloroform and the organic
fractions were pooled and retained. The chloroform extracts of the supernatants
were then evaporated using a Vacufuge (Eppendorf) and resuspended in
100–200 μL of chloroform to normalize to the ﬁnal OD600 of the cultures. The
extracts were then subjected to thin-layer chromatography on silica gel 60 plates
(10 × 10 cm, 250 μm thick; Sigma) using ethanol/cyclohexane/water/ethyl acetate/
acetic acid (5:25:2.5:35:5) as a solvent as described previously42. The 55Fe-loaded
mycobactins and carboxymycobactins, as well as radiolabeled salicylic acid substrate were used as controls. Plates were allowed to dry and subjected to autoradiography for 72 h. The phosphor screen was imaged using a Typhoon Trio+
Imager (GE).
Lipidomics. Total lipid extraction of M. tuberculosis was performed as previously
described15 with modiﬁcations. M. tuberculosis mc26230 (parent strain), Δrv0455c
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(ML2203), and complementation strain (ML2205) were pre-grown in 20 mL selfmade 7H9 medium without additional iron (<0.1 μM Fe) for 1 week to deplete
intracellular iron stores. Cells were harvested and washed twice with PBS buffer.
Afterward, the cells were grown in 120 mL detergent-free, low-iron 7H9 medium
(supplemented with 1 μM ammonium ferric citrate, 0.5% glycerol, 24 μg/mL
pantothenate, and 0.2% casamino acids) at an initial OD600 of 0.04 for 8–11 days.
The cells were harvested after the cultures reached an OD600 of ~2. Approximately
1 g of the cell pellets were extracted two times with 15 mL CHCl3:MeOH (1:2) for
2 h and 6 mL CHCl3:MeOH (1:1) for 2 h, respectively. The total lipid extracts were
dried in the vacuum. Lipid masses per sample were measured, and dried lipids were
resuspended to 1 mg/mL in CHCl3:MeOH (1:1). Fifty microgram of total lipid per
technical and biological run were injected for HPLC/MS analyses. All experiments
were done in quadruplicate. Mass-normalized samples of the lipid extracts containing MBTs and cMBTs were analyzed using an Agilent 6520 accurate-mass
quadrupole time-of-ﬂight mass spectrometer with an electrospray source and an
Agilent 1200 series HPLC system with a Poroshell C18 column (3 mm × 50 mm).
The elution solvent was a mixture of methanol:water (A) (7:3) and n-propanol:cyclohexane (9:1) with 2 mM ammonium formate (B). Solvent ﬂow was carried
out at a rate of 0.15 mL/min. A gradient from 0% B (0–4 min) with a linear
gradient (4–13 min) to 100% B (13–22 min) was used. Mycobactin and carboxymycobactin annotations were made based on 10 ppm mass match of ions with the
indicated core polyketide-peptide12 and deduced acyl chain length of the mono- or
di-carboxylate unit.
Protein expression and puriﬁcation. The C-terminal StrepII-His8 tagged
MSMEG_349433–153 was expressed in E.coli BL21 (DE3) by periplasmic expression
vectors pML4249 or pML4604 containing a E.coli signal sequence (Table S2). One
liter of Luria–Bertani (LB) medium was used for producing the unlabeled protein,
and two liters of M9 minimal medium containing 4 g 15NH4Cl were used for
producing 15N-labeled proteins. Cells were grown at 37 °C until the cell density
reached an OD600 of ~1.8. Then the cells were induced with 1 mM isopropyl-β-Dthiogalactopyranoside (IPTG) at 18 °C overnight. Afterward, cells were harvested
by centrifugation and lysed by sonication in ice-cold lysis buffer (150 mM NaCl,
30 mM Tris, 1 mM PMSF [pH 7.5]). Cell lysate was clariﬁed by centrifugation, and
the supernatant ﬂowed through Ni-NTA column. Approximately 20 mg of the
protein was obtained by Ni afﬁnity puriﬁcation. Afterward, the afﬁnity tag was
removed by enterokinase, and a total of ~15 mg isotopically labeled protein was
obtained after size exclusion chromatography via Superdex 75 gel ﬁltration
column (GE).
Carboxymycobactin-binding experiments. NMR experiments were collected at
25 °C on a Bruker Avance II (700 MHz 1H) spectrometer equipped with a cryogenic triple-resonance probe, processed with NMRPIPE44, and analyzed with
NMRVIEW45. 15N-labeled protein samples were prepared at 50 μM in a buffer
containing 50 mM sodium phosphates [pH 6.5]. NMR titrations were performed
with 20 mM stock solution of iron-free carboxymycobactin S (EMC company,
Germany) dissolved in 100% DMSO. carboxymycobactin S was mixed with the
StrepII-His8 tagged MSMEG_349433–153 protein at a molar ratio of 2:1. The mixture was incubated at 37 °C for 1 h, followed by acquisition of 2D 1H-15N
HSQC data.
Crystallization of the MSMEG_3494 protein. After enterokinase cleavage and
subsequent puriﬁcation as described above, a solution of MSMEG_349433–153
(1 mg/mL) was dialyzed overnight into a 20 mM Tris-HCl buffer (pH 7.75) at 4 °C.
After centrifugation to clarify the solution, the protein was concentrated to 8 mg/
mL using an Amicon Ultra 10 KDa MWCO centrifugal ﬁlter. Initial crystallization
trials were conducted in 96-well sitting drop plates at both 4 °C and room temperature with either a 1:1 or 2:1 ratio of protein to precipitant. Crystals with a
hexagonal prism geometry were observed in well F1 of the JBScreen Kinase HTS
precipitant screen, containing 0.2 M LiAc and 28% PEG 4 K. After further optimization, quality crystals for data collection were grown at room temperature after
mixing 2 μL of a solution containing 8 mg/mL MSMEG_349333–153 in a 20 mM
Tris-HCl buffer with a pH of 7.75 with 1 μL of precipitant solution (0.2 M LiAc,
26% PEG 4 K) and equilibration in a hanging drop plate with 300 μL of precipitation solution. To obtain heavy atom derivative, the crystals were soaked with
1.5 M NaBr in the cryoprotective buffer containing 0.2 M LiAc, 26% PEG 4 K, and
20% glycerol for 180 sec before ﬂash freezing in liquid nitrogen.
X-ray data acquisition and structure determination. MAD data from the NaBr
soaked crystals were collected at the Stanford Synchrotron Radiation Lightsource
(SSRL) using beam line 9–2. Nine hundred frames with an oscillation width of 0.2°
were collected for each wavelength of the experiment. SHELX C/D/E46 was used to
identify positions of 11 bromide ions. 115 out of 127 residues for each chain were
built automatically with Buccaneer from CCP4i247. The model was completed and
reﬁned to 2.1 Å resolution using COOT48 and REFMAC549. In the ﬁnal model,
residues 155–158 of chain A and residues 32, 33, 156–158 of chain B were disordered.
Residues 32 and 154–158 were artifacts of the expression and puriﬁcation processes
used. The data quality and reﬁnement statistics are presented in Table S4. The
structure coordinates and data have been deposited in the PDB (PDB ID: 7REF).
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Structure validation and analysis. The conformation and nonbonded interaction
parameters were evaluated using the program MolProbity50. Structures were rendered, examined, and visualized with PyMol (Molecular Graphics System, Version
2.5, Schrödinger, LLC). Electrostatic potentials were calculated in units of kT/e,
where k is the Boltzmann constant, T is the absolute temperature, and e is the
proton charge, using the programs PDB2PQR51 and APBS52. Evolutionarily conserved residues were identiﬁed using the ConSurf server, with the percentage
sequence identity range spanning from 35 to 95% during multiple sequence
alignment of closest 150 sequences53.
Generation of Rv0455c antiserum. The C-terminal hexahistidine tagged
Rv0455c31–148 (Rv0455cΔSP) was produced in E.coli BL21 (DE3) using the periplasmic expression vector pML4212 containing a signal sequence from E.coli
OmpF. After Ni(II)-afﬁnity puriﬁcation, 10 mg puriﬁed protein was loaded on 8%
SDS-PAGE gels for separation. The recombinant Rv0455c protein bands were cut
from the gels. Approximately 5 mg of the protein was extracted and used for
producing the polyclonal antiserum in rabbits (GenScript).
Subcellular localization for Rv0455c and its variants in M. tuberculosis. The
subcellular localization experiments were performed using previous procedure54. The
M. tuberculosis strains expressing the original Rv0455c or the Rv0455c variants were
grown in 500 mL 7H9 [10 μM Fe3+] medium till OD600 reached ~0.6. The cell pellet
and supernatant were separated by centrifugation at 3000 g for 10 min. To obtain
culture ﬁltrate (CF) fraction, the supernatant was ﬁltered through 0.22 μm Millipore
ﬁltration system and then concentrated ~200-fold to a ﬁnal volume of 2.5 mL using a
3-kDa-cutoff Amicon (Millipore) ultraﬁltration device. The cell pellet was resuspended in 10 mL PBS buffer containing 1 mM phenylmethylsulfonyl (PMSF) and
lysed by sonication (24 w output power, 15 min “ON” in total). Cell debris was
removed from the lysate by centrifugation at 3200 × g for 10 min at 4 °C. The 10 mL
clear lysate (WCL) was centrifuged at 100,000 × g for 1 h at 4 °C. The supernatant
(Sol1) was transferred to a separate tube, and the pellet (Mem1) was resuspended in
another 10 mL PBS buffer. Afterward, both S1 and M1 fractions were centrifuged at
100,000 × g for 1 h at 4 °C. The supernatant (Sol2) containing the cytosolic fraction
was transferred to a new tube. The membrane pellet (Mem2) was resuspended in
10 mL PBS with 1% SDS. Finally, 5 μL of each fraction taken from the WCL, Mem2,
Sol2, and CF was analyzed by 8% SDS-PAGE gels and Western blots, as shown in
Fig. 2b and S7b. The membrane protein EccB5, the cytosolic protein GlpX, and the
culture ﬁltrate proteins Ag85 and CFP10 were detected by rabbit polyclonal antiEccB5 antibody (1:1000), anti-GlpX antibody (1:1000), anti-Ag85 antibody (1:5000,
BEI Resources) and anti-CFP10 antibody (1:5000, BEI Resources), respectively, as
controls. The Rv0455c and its variants were detected by the rabbit polyclonal antiRv0455c antibody (1:300). To analyze the proportion of the secreted Rv0455c by M.
tuberculosis, 20 μL of the whole-cell lysate and 5 μL of the culture ﬁltrate (2.5 mL)
were loaded into 8% SDS-PAGE gels for Western blot. The secreted Rv0455c versus
the cell-associated Rv0455c is ~1:1 in M. tuberculosis mc26230 (Fig. S7a) and ~2:3 in
M. tuberculosis mc26206 (Fig. S7c). Quantitative image analysis of western blots was
done using ImageJ 1.46r.
Mouse infection experiments. The phthiocerol dimycocerosates (PDIM) of the
strains for mice experiments was conﬁrmed by thin-layer chromatography (Fig.
S1h) using previous procedure43. We utilized an inhalation exposure system (GlasCol) to infect 7–8 weeks old female C57BL/6 mice (Jackson Laboratory) with the
M. tuberculosis strains (ML2710, ML2711, and ML2701) which are listed in
Table S1. Cultures used for infections were in mid-log phase of growth and prepared such that each mouse received ~200 bacilli. At the indicated time points,
mice were euthanized by carbon dioxide inhalation. Lungs and spleens were isolated and homogenized in PBS using a bullet-blender (Next Advance). Dilutions of
the homogenates were cultured on 7H10 agar supplemented with 20 μM hemin
(Sigma-Aldrich) to determine the number of bacteria (CFU). On day 28 and day 70
post infection, the left upper lung lobes were preserved in formalin. The preserved
tissues were embedded in parafﬁn wax, sliced, and stained with hematoxylin and
eosin at the Weill Cornell Laboratory of Comparative Pathology. The mice
experiments were repeated once.
Ethics statement. All animal experiments were performed following National
Institutes of Health guidelines for housing and care of laboratory animals and
performed in accordance with institutional regulations after protocol review and
approval by the Institutional Animal Care and Use Committee of Weill Cornell
Medical College (Protocol Number 0601441 A).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Atomic coordinates of the MSMEG_3494 crystal structure have been deposited in the
Protein Data Bank under accession number 7REF. The data generated in this study are
provided in the Supplementary Information and Source Data ﬁles. Additional data are
available upon request. Source data are provided with this paper.
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